Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 19 Breast Neoplasms 16 Pain 8 Agnosia 8 Lung Neoplasms 6 Prostatic Neoplasms 5 Neoplasms 5 Stomach Neoplasms 4 Colorectal Neoplasms 4 Colonic Neoplasms 3 Supratentorial Neoplasms 2 Postoperative Complications 2 Meningioma 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Sleep Deprivation 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain, Intractable 1 Ovarian Cysts 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Malignant Neoplasms of Male Genital Organs 1 Liver Neoplasms 1 Liver Diseases 1 Leiomyoma 1 Kidney Neoplasms 1 Intraoperative Complications 1

Interventions

Saline Solution 3 Carboplatin 2 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 olaparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Neoadjuvant Therapy 1 Antineoplastic Agents 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Ovarian Cancer × Ropivacaine × Clear all

NCT04065009 2024-01-11

IPLA-OVCA

Karolinska Institutet

Phase 3 Active not recruiting

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡